FTRE Q4 2023 Earnings — Fortrea Holdings Inc. Revenue & Financial Results | Market Cap Arena

FTREFortrea Holdings Inc.

$851M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$775M+54.3% YoY

Gross Profit

$120M15.4% margin

Operating Income

-$11M-1.4% margin

Net Income

-$36M-4.6% margin

EPS (Diluted)

$-0.41

QoQ Revenue Growth

+8.6%

Cash Flow

Operating Cash Flow

$12M

Free Cash Flow

$3M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$4.3B

Total Liabilities

$2.6B

Stockholders' Equity

$1.7B

Cash & Equivalents

$109M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$775M	$503M	+54.3%
Gross Profit	$120M	$284M	-57.9%
Operating Income	-$11M	-$8M	-28.9%
Net Income	-$36M	$27M	-234.8%

Revenue Segments

Clinical Services Segment

$1.4B100%

Geographic Segments

North America

$814M53%

Europe

$423M27%

Other Geographical Areas

$303M20%